nodes	percent_of_prediction	percent_of_DWPC	metapath
Zolmitriptan—CYP1A2—Alitretinoin—peripheral nervous system neoplasm	0.0579	0.457	CbGbCtD
Zolmitriptan—CYP1A2—Dacarbazine—peripheral nervous system neoplasm	0.0463	0.365	CbGbCtD
Zolmitriptan—HTR1D—meninx—peripheral nervous system neoplasm	0.0429	0.148	CbGeAlD
Zolmitriptan—HTR1F—trigeminal nerve—peripheral nervous system neoplasm	0.0427	0.148	CbGeAlD
Zolmitriptan—HTR1B—dura mater—peripheral nervous system neoplasm	0.0407	0.141	CbGeAlD
Zolmitriptan—HTR1D—dura mater—peripheral nervous system neoplasm	0.0394	0.136	CbGeAlD
Zolmitriptan—CYP1A2—Etoposide—peripheral nervous system neoplasm	0.0226	0.179	CbGbCtD
Zolmitriptan—HTR1B—trigeminal nerve—peripheral nervous system neoplasm	0.0175	0.0605	CbGeAlD
Zolmitriptan—HTR1D—trigeminal nerve—peripheral nervous system neoplasm	0.017	0.0586	CbGeAlD
Zolmitriptan—HTR1F—ganglion—peripheral nervous system neoplasm	0.0154	0.0533	CbGeAlD
Zolmitriptan—HTR1B—cranial nerve—peripheral nervous system neoplasm	0.0125	0.0431	CbGeAlD
Zolmitriptan—HTR1D—cranial nerve—peripheral nervous system neoplasm	0.0121	0.0418	CbGeAlD
Zolmitriptan—HTR1B—ganglion—peripheral nervous system neoplasm	0.00632	0.0218	CbGeAlD
Zolmitriptan—HTR1D—ganglion—peripheral nervous system neoplasm	0.00612	0.0211	CbGeAlD
Zolmitriptan—HTR1A—ganglion—peripheral nervous system neoplasm	0.0051	0.0176	CbGeAlD
Zolmitriptan—MAOA—nerve—peripheral nervous system neoplasm	0.00472	0.0163	CbGeAlD
Zolmitriptan—MAOA—ganglion—peripheral nervous system neoplasm	0.00466	0.0161	CbGeAlD
Zolmitriptan—HTR1B—trigeminal ganglion—peripheral nervous system neoplasm	0.0031	0.0107	CbGeAlD
Zolmitriptan—HTR1D—trigeminal ganglion—peripheral nervous system neoplasm	0.003	0.0104	CbGeAlD
Zolmitriptan—HTR1B—brainstem—peripheral nervous system neoplasm	0.00275	0.00949	CbGeAlD
Zolmitriptan—HTR1D—brainstem—peripheral nervous system neoplasm	0.00266	0.00919	CbGeAlD
Zolmitriptan—MAOA—trigeminal ganglion—peripheral nervous system neoplasm	0.00229	0.0079	CbGeAlD
Zolmitriptan—HTR1A—brainstem—peripheral nervous system neoplasm	0.00222	0.00766	CbGeAlD
Zolmitriptan—MAOA—parotid gland—peripheral nervous system neoplasm	0.00216	0.00745	CbGeAlD
Zolmitriptan—MAOA—brainstem—peripheral nervous system neoplasm	0.00202	0.00699	CbGeAlD
Zolmitriptan—HTR1A—cerebellum—peripheral nervous system neoplasm	0.00109	0.00377	CbGeAlD
Zolmitriptan—MAOA—cerebellum—peripheral nervous system neoplasm	0.000998	0.00345	CbGeAlD
Zolmitriptan—Sumatriptan—ABCB1—peripheral nervous system neoplasm	0.000902	0.553	CrCbGaD
Zolmitriptan—Eletriptan—ABCB1—peripheral nervous system neoplasm	0.00073	0.447	CrCbGaD
Zolmitriptan—HTR1F—GPCRs, Other—ADGRV1—peripheral nervous system neoplasm	0.000599	0.151	CbGpPWpGaD
Zolmitriptan—MAOA—Neurotransmitter Clearance In The Synaptic Cleft—BCHE—peripheral nervous system neoplasm	0.000379	0.0952	CbGpPWpGaD
Zolmitriptan—Eosinophilia—Epirubicin—peripheral nervous system neoplasm	0.000298	0.000516	CcSEcCtD
Zolmitriptan—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000298	0.000516	CcSEcCtD
Zolmitriptan—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000298	0.000516	CcSEcCtD
Zolmitriptan—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000298	0.000515	CcSEcCtD
Zolmitriptan—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.000297	0.000514	CcSEcCtD
Zolmitriptan—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000296	0.000511	CcSEcCtD
Zolmitriptan—Pancreatitis—Epirubicin—peripheral nervous system neoplasm	0.000296	0.000511	CcSEcCtD
Zolmitriptan—Orthostatic hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000295	0.00051	CcSEcCtD
Zolmitriptan—Angina pectoris—Epirubicin—peripheral nervous system neoplasm	0.000294	0.000508	CcSEcCtD
Zolmitriptan—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000292	0.000504	CcSEcCtD
Zolmitriptan—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.00029	0.000502	CcSEcCtD
Zolmitriptan—Bronchitis—Epirubicin—peripheral nervous system neoplasm	0.00029	0.000501	CcSEcCtD
Zolmitriptan—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000289	0.0005	CcSEcCtD
Zolmitriptan—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000289	0.000499	CcSEcCtD
Zolmitriptan—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000288	0.000498	CcSEcCtD
Zolmitriptan—Gastritis—Doxorubicin—peripheral nervous system neoplasm	0.000286	0.000494	CcSEcCtD
Zolmitriptan—Pain—Cisplatin—peripheral nervous system neoplasm	0.000285	0.000494	CcSEcCtD
Zolmitriptan—Muscular weakness—Doxorubicin—peripheral nervous system neoplasm	0.000285	0.000492	CcSEcCtD
Zolmitriptan—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000281	0.000486	CcSEcCtD
Zolmitriptan—Influenza—Doxorubicin—peripheral nervous system neoplasm	0.000279	0.000482	CcSEcCtD
Zolmitriptan—Dysphagia—Doxorubicin—peripheral nervous system neoplasm	0.000279	0.000482	CcSEcCtD
Zolmitriptan—Pollakiuria—Epirubicin—peripheral nervous system neoplasm	0.000279	0.000482	CcSEcCtD
Zolmitriptan—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000278	0.000481	CcSEcCtD
Zolmitriptan—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000277	0.000479	CcSEcCtD
Zolmitriptan—Eosinophilia—Doxorubicin—peripheral nervous system neoplasm	0.000276	0.000478	CcSEcCtD
Zolmitriptan—Photosensitivity reaction—Epirubicin—peripheral nervous system neoplasm	0.000275	0.000476	CcSEcCtD
Zolmitriptan—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000275	0.000476	CcSEcCtD
Zolmitriptan—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000275	0.000475	CcSEcCtD
Zolmitriptan—Weight increased—Epirubicin—peripheral nervous system neoplasm	0.000274	0.000475	CcSEcCtD
Zolmitriptan—Pancreatitis—Doxorubicin—peripheral nervous system neoplasm	0.000273	0.000473	CcSEcCtD
Zolmitriptan—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000273	0.000472	CcSEcCtD
Zolmitriptan—Hyperglycaemia—Epirubicin—peripheral nervous system neoplasm	0.000272	0.00047	CcSEcCtD
Zolmitriptan—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000272	0.00047	CcSEcCtD
Zolmitriptan—Angina pectoris—Doxorubicin—peripheral nervous system neoplasm	0.000272	0.00047	CcSEcCtD
Zolmitriptan—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000271	0.000468	CcSEcCtD
Zolmitriptan—Pneumonia—Epirubicin—peripheral nervous system neoplasm	0.00027	0.000468	CcSEcCtD
Zolmitriptan—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000269	0.000465	CcSEcCtD
Zolmitriptan—Bronchitis—Doxorubicin—peripheral nervous system neoplasm	0.000268	0.000464	CcSEcCtD
Zolmitriptan—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000268	0.000464	CcSEcCtD
Zolmitriptan—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000266	0.000461	CcSEcCtD
Zolmitriptan—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000266	0.00046	CcSEcCtD
Zolmitriptan—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000264	0.000457	CcSEcCtD
Zolmitriptan—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000264	0.000456	CcSEcCtD
Zolmitriptan—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	0.000263	0.000456	CcSEcCtD
Zolmitriptan—Stomatitis—Epirubicin—peripheral nervous system neoplasm	0.000262	0.000453	CcSEcCtD
Zolmitriptan—Jaundice—Epirubicin—peripheral nervous system neoplasm	0.000262	0.000453	CcSEcCtD
Zolmitriptan—Pain—Etoposide—peripheral nervous system neoplasm	0.000262	0.000452	CcSEcCtD
Zolmitriptan—Constipation—Etoposide—peripheral nervous system neoplasm	0.000262	0.000452	CcSEcCtD
Zolmitriptan—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	0.000261	0.000452	CcSEcCtD
Zolmitriptan—Urinary tract infection—Epirubicin—peripheral nervous system neoplasm	0.000261	0.000452	CcSEcCtD
Zolmitriptan—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000259	0.000448	CcSEcCtD
Zolmitriptan—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000258	0.000447	CcSEcCtD
Zolmitriptan—Sweating—Epirubicin—peripheral nervous system neoplasm	0.000258	0.000446	CcSEcCtD
Zolmitriptan—Pollakiuria—Doxorubicin—peripheral nervous system neoplasm	0.000258	0.000446	CcSEcCtD
Zolmitriptan—Haematuria—Epirubicin—peripheral nervous system neoplasm	0.000256	0.000443	CcSEcCtD
Zolmitriptan—Photosensitivity reaction—Doxorubicin—peripheral nervous system neoplasm	0.000255	0.00044	CcSEcCtD
Zolmitriptan—Weight increased—Doxorubicin—peripheral nervous system neoplasm	0.000254	0.000439	CcSEcCtD
Zolmitriptan—Epistaxis—Epirubicin—peripheral nervous system neoplasm	0.000254	0.000439	CcSEcCtD
Zolmitriptan—Sinusitis—Epirubicin—peripheral nervous system neoplasm	0.000252	0.000436	CcSEcCtD
Zolmitriptan—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000252	0.000436	CcSEcCtD
Zolmitriptan—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	0.000252	0.000435	CcSEcCtD
Zolmitriptan—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000251	0.000434	CcSEcCtD
Zolmitriptan—Pneumonia—Doxorubicin—peripheral nervous system neoplasm	0.00025	0.000433	CcSEcCtD
Zolmitriptan—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.00025	0.000433	CcSEcCtD
Zolmitriptan—Dizziness—Vincristine—peripheral nervous system neoplasm	0.00025	0.000432	CcSEcCtD
Zolmitriptan—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000249	0.000431	CcSEcCtD
Zolmitriptan—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000247	0.000427	CcSEcCtD
Zolmitriptan—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000247	0.000427	CcSEcCtD
Zolmitriptan—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000246	0.000425	CcSEcCtD
Zolmitriptan—Bradycardia—Epirubicin—peripheral nervous system neoplasm	0.000246	0.000425	CcSEcCtD
Zolmitriptan—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000245	0.000425	CcSEcCtD
Zolmitriptan—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000244	0.000422	CcSEcCtD
Zolmitriptan—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000243	0.00042	CcSEcCtD
Zolmitriptan—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	0.000242	0.000419	CcSEcCtD
Zolmitriptan—Jaundice—Doxorubicin—peripheral nervous system neoplasm	0.000242	0.000419	CcSEcCtD
Zolmitriptan—Rhinitis—Epirubicin—peripheral nervous system neoplasm	0.000242	0.000418	CcSEcCtD
Zolmitriptan—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000242	0.000418	CcSEcCtD
Zolmitriptan—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000242	0.000418	CcSEcCtD
Zolmitriptan—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	0.000242	0.000418	CcSEcCtD
Zolmitriptan—Urinary tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000242	0.000418	CcSEcCtD
Zolmitriptan—MAOA—Dopamine metabolism—TH—peripheral nervous system neoplasm	0.000242	0.0607	CbGpPWpGaD
Zolmitriptan—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	0.00024	0.000415	CcSEcCtD
Zolmitriptan—Vomiting—Vincristine—peripheral nervous system neoplasm	0.00024	0.000415	CcSEcCtD
Zolmitriptan—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.00024	0.000414	CcSEcCtD
Zolmitriptan—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	0.00024	0.000414	CcSEcCtD
Zolmitriptan—Sweating—Doxorubicin—peripheral nervous system neoplasm	0.000238	0.000412	CcSEcCtD
Zolmitriptan—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	0.000238	0.000412	CcSEcCtD
Zolmitriptan—Rash—Vincristine—peripheral nervous system neoplasm	0.000238	0.000412	CcSEcCtD
Zolmitriptan—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000238	0.000411	CcSEcCtD
Zolmitriptan—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	0.000238	0.000411	CcSEcCtD
Zolmitriptan—Haematuria—Doxorubicin—peripheral nervous system neoplasm	0.000237	0.00041	CcSEcCtD
Zolmitriptan—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	0.000237	0.00041	CcSEcCtD
Zolmitriptan—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	0.000237	0.000409	CcSEcCtD
Zolmitriptan—Headache—Vincristine—peripheral nervous system neoplasm	0.000237	0.000409	CcSEcCtD
Zolmitriptan—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	0.000235	0.000406	CcSEcCtD
Zolmitriptan—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	0.000233	0.000404	CcSEcCtD
Zolmitriptan—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000233	0.000403	CcSEcCtD
Zolmitriptan—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000228	0.000395	CcSEcCtD
Zolmitriptan—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	0.000227	0.000393	CcSEcCtD
Zolmitriptan—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000225	0.00039	CcSEcCtD
Zolmitriptan—Tinnitus—Epirubicin—peripheral nervous system neoplasm	0.000225	0.000389	CcSEcCtD
Zolmitriptan—Nausea—Vincristine—peripheral nervous system neoplasm	0.000224	0.000388	CcSEcCtD
Zolmitriptan—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	0.000224	0.000387	CcSEcCtD
Zolmitriptan—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	0.000224	0.000387	CcSEcCtD
Zolmitriptan—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000222	0.000384	CcSEcCtD
Zolmitriptan—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000222	0.000383	CcSEcCtD
Zolmitriptan—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	0.000221	0.000381	CcSEcCtD
Zolmitriptan—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	0.00022	0.00038	CcSEcCtD
Zolmitriptan—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000219	0.00038	CcSEcCtD
Zolmitriptan—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	0.000219	0.000379	CcSEcCtD
Zolmitriptan—Angiopathy—Epirubicin—peripheral nervous system neoplasm	0.000219	0.000379	CcSEcCtD
Zolmitriptan—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	0.000219	0.000379	CcSEcCtD
Zolmitriptan—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	0.000218	0.000377	CcSEcCtD
Zolmitriptan—Chills—Epirubicin—peripheral nervous system neoplasm	0.000217	0.000374	CcSEcCtD
Zolmitriptan—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000216	0.000374	CcSEcCtD
Zolmitriptan—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	0.000216	0.000373	CcSEcCtD
Zolmitriptan—MAOA—Biogenic Amine Synthesis—TH—peripheral nervous system neoplasm	0.000215	0.0541	CbGpPWpGaD
Zolmitriptan—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000212	0.000367	CcSEcCtD
Zolmitriptan—Rash—Cisplatin—peripheral nervous system neoplasm	0.00021	0.000364	CcSEcCtD
Zolmitriptan—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.00021	0.000364	CcSEcCtD
Zolmitriptan—Erythema—Epirubicin—peripheral nervous system neoplasm	0.00021	0.000363	CcSEcCtD
Zolmitriptan—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000209	0.000362	CcSEcCtD
Zolmitriptan—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	0.000208	0.00036	CcSEcCtD
Zolmitriptan—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	0.000207	0.000358	CcSEcCtD
Zolmitriptan—Tension—Epirubicin—peripheral nervous system neoplasm	0.000206	0.000357	CcSEcCtD
Zolmitriptan—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	0.000206	0.000356	CcSEcCtD
Zolmitriptan—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.000204	0.000353	CcSEcCtD
Zolmitriptan—Back pain—Epirubicin—peripheral nervous system neoplasm	0.000203	0.000351	CcSEcCtD
Zolmitriptan—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	0.000203	0.00035	CcSEcCtD
Zolmitriptan—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000202	0.00035	CcSEcCtD
Zolmitriptan—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	0.000202	0.000349	CcSEcCtD
Zolmitriptan—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000202	0.000349	CcSEcCtD
Zolmitriptan—Chills—Doxorubicin—peripheral nervous system neoplasm	0.0002	0.000346	CcSEcCtD
Zolmitriptan—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	0.000199	0.000345	CcSEcCtD
Zolmitriptan—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000198	0.000343	CcSEcCtD
Zolmitriptan—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.000195	0.000337	CcSEcCtD
Zolmitriptan—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000194	0.000336	CcSEcCtD
Zolmitriptan—Erythema—Doxorubicin—peripheral nervous system neoplasm	0.000194	0.000336	CcSEcCtD
Zolmitriptan—Agitation—Epirubicin—peripheral nervous system neoplasm	0.000193	0.000334	CcSEcCtD
Zolmitriptan—Rash—Etoposide—peripheral nervous system neoplasm	0.000193	0.000334	CcSEcCtD
Zolmitriptan—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000193	0.000333	CcSEcCtD
Zolmitriptan—Headache—Etoposide—peripheral nervous system neoplasm	0.000192	0.000331	CcSEcCtD
Zolmitriptan—Tension—Doxorubicin—peripheral nervous system neoplasm	0.000191	0.00033	CcSEcCtD
Zolmitriptan—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	0.00019	0.000329	CcSEcCtD
Zolmitriptan—Malaise—Epirubicin—peripheral nervous system neoplasm	0.000189	0.000328	CcSEcCtD
Zolmitriptan—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.000189	0.000326	CcSEcCtD
Zolmitriptan—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.000189	0.000326	CcSEcCtD
Zolmitriptan—Syncope—Epirubicin—peripheral nervous system neoplasm	0.000188	0.000326	CcSEcCtD
Zolmitriptan—Leukopenia—Epirubicin—peripheral nervous system neoplasm	0.000188	0.000325	CcSEcCtD
Zolmitriptan—Back pain—Doxorubicin—peripheral nervous system neoplasm	0.000188	0.000325	CcSEcCtD
Zolmitriptan—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	0.000187	0.000323	CcSEcCtD
Zolmitriptan—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.000186	0.000321	CcSEcCtD
Zolmitriptan—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.000185	0.000319	CcSEcCtD
Zolmitriptan—Cough—Epirubicin—peripheral nervous system neoplasm	0.000183	0.000317	CcSEcCtD
Zolmitriptan—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.000182	0.000315	CcSEcCtD
Zolmitriptan—Nausea—Etoposide—peripheral nervous system neoplasm	0.000182	0.000314	CcSEcCtD
Zolmitriptan—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000181	0.000314	CcSEcCtD
Zolmitriptan—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	0.00018	0.000312	CcSEcCtD
Zolmitriptan—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.000179	0.000309	CcSEcCtD
Zolmitriptan—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.000179	0.000309	CcSEcCtD
Zolmitriptan—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.000179	0.000309	CcSEcCtD
Zolmitriptan—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.000179	0.000309	CcSEcCtD
Zolmitriptan—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.000178	0.000308	CcSEcCtD
Zolmitriptan—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.000177	0.000306	CcSEcCtD
Zolmitriptan—Malaise—Doxorubicin—peripheral nervous system neoplasm	0.000175	0.000303	CcSEcCtD
Zolmitriptan—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.000175	0.000302	CcSEcCtD
Zolmitriptan—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.000175	0.000302	CcSEcCtD
Zolmitriptan—Syncope—Doxorubicin—peripheral nervous system neoplasm	0.000174	0.000301	CcSEcCtD
Zolmitriptan—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	0.000174	0.000301	CcSEcCtD
Zolmitriptan—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.000173	0.000299	CcSEcCtD
Zolmitriptan—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.000172	0.000297	CcSEcCtD
Zolmitriptan—Oedema—Epirubicin—peripheral nervous system neoplasm	0.000171	0.000297	CcSEcCtD
Zolmitriptan—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.000171	0.000297	CcSEcCtD
Zolmitriptan—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.000171	0.000295	CcSEcCtD
Zolmitriptan—Infection—Epirubicin—peripheral nervous system neoplasm	0.00017	0.000295	CcSEcCtD
Zolmitriptan—Cough—Doxorubicin—peripheral nervous system neoplasm	0.00017	0.000293	CcSEcCtD
Zolmitriptan—Shock—Epirubicin—peripheral nervous system neoplasm	0.000169	0.000292	CcSEcCtD
Zolmitriptan—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.000168	0.000291	CcSEcCtD
Zolmitriptan—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.000168	0.000291	CcSEcCtD
Zolmitriptan—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.000168	0.00029	CcSEcCtD
Zolmitriptan—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000168	0.00029	CcSEcCtD
Zolmitriptan—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000167	0.000289	CcSEcCtD
Zolmitriptan—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.000167	0.000288	CcSEcCtD
Zolmitriptan—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000166	0.000287	CcSEcCtD
Zolmitriptan—Myalgia—Doxorubicin—peripheral nervous system neoplasm	0.000165	0.000286	CcSEcCtD
Zolmitriptan—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	0.000165	0.000286	CcSEcCtD
Zolmitriptan—Chest pain—Doxorubicin—peripheral nervous system neoplasm	0.000165	0.000286	CcSEcCtD
Zolmitriptan—Anxiety—Doxorubicin—peripheral nervous system neoplasm	0.000165	0.000285	CcSEcCtD
Zolmitriptan—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000163	0.000283	CcSEcCtD
Zolmitriptan—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.000163	0.000283	CcSEcCtD
Zolmitriptan—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.000162	0.00028	CcSEcCtD
Zolmitriptan—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.00016	0.000277	CcSEcCtD
Zolmitriptan—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.000159	0.000274	CcSEcCtD
Zolmitriptan—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.000159	0.000274	CcSEcCtD
Zolmitriptan—Infection—Doxorubicin—peripheral nervous system neoplasm	0.000158	0.000273	CcSEcCtD
Zolmitriptan—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000156	0.00027	CcSEcCtD
Zolmitriptan—Shock—Doxorubicin—peripheral nervous system neoplasm	0.000156	0.00027	CcSEcCtD
Zolmitriptan—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000156	0.000269	CcSEcCtD
Zolmitriptan—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000155	0.000269	CcSEcCtD
Zolmitriptan—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000155	0.000268	CcSEcCtD
Zolmitriptan—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.000155	0.000268	CcSEcCtD
Zolmitriptan—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.000154	0.000266	CcSEcCtD
Zolmitriptan—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000154	0.000266	CcSEcCtD
Zolmitriptan—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.000153	0.000265	CcSEcCtD
Zolmitriptan—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000153	0.000264	CcSEcCtD
Zolmitriptan—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000152	0.000264	CcSEcCtD
Zolmitriptan—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.000151	0.000262	CcSEcCtD
Zolmitriptan—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000151	0.000261	CcSEcCtD
Zolmitriptan—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.000149	0.000258	CcSEcCtD
Zolmitriptan—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000148	0.000256	CcSEcCtD
Zolmitriptan—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000147	0.000254	CcSEcCtD
Zolmitriptan—Pain—Epirubicin—peripheral nervous system neoplasm	0.000147	0.000254	CcSEcCtD
Zolmitriptan—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000145	0.00025	CcSEcCtD
Zolmitriptan—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000143	0.000248	CcSEcCtD
Zolmitriptan—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000142	0.000246	CcSEcCtD
Zolmitriptan—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000141	0.000245	CcSEcCtD
Zolmitriptan—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000141	0.000244	CcSEcCtD
Zolmitriptan—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000141	0.000244	CcSEcCtD
Zolmitriptan—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.00014	0.000242	CcSEcCtD
Zolmitriptan—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.00014	0.000241	CcSEcCtD
Zolmitriptan—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000138	0.000238	CcSEcCtD
Zolmitriptan—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000137	0.000237	CcSEcCtD
Zolmitriptan—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000136	0.000236	CcSEcCtD
Zolmitriptan—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000136	0.000235	CcSEcCtD
Zolmitriptan—Pain—Doxorubicin—peripheral nervous system neoplasm	0.000136	0.000235	CcSEcCtD
Zolmitriptan—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000136	0.000234	CcSEcCtD
Zolmitriptan—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000136	0.000234	CcSEcCtD
Zolmitriptan—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000131	0.000226	CcSEcCtD
Zolmitriptan—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.00013	0.000224	CcSEcCtD
Zolmitriptan—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000126	0.000218	CcSEcCtD
Zolmitriptan—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000126	0.000218	CcSEcCtD
Zolmitriptan—MAOA—SIDS Susceptibility Pathways—PHOX2B—peripheral nervous system neoplasm	0.000125	0.0315	CbGpPWpGaD
Zolmitriptan—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000125	0.000217	CcSEcCtD
Zolmitriptan—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.000125	0.000217	CcSEcCtD
Zolmitriptan—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000123	0.000213	CcSEcCtD
Zolmitriptan—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000121	0.00021	CcSEcCtD
Zolmitriptan—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000117	0.000203	CcSEcCtD
Zolmitriptan—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000117	0.000202	CcSEcCtD
Zolmitriptan—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000114	0.000197	CcSEcCtD
Zolmitriptan—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000113	0.000196	CcSEcCtD
Zolmitriptan—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000112	0.000194	CcSEcCtD
Zolmitriptan—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000109	0.000189	CcSEcCtD
Zolmitriptan—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000109	0.000188	CcSEcCtD
Zolmitriptan—Rash—Epirubicin—peripheral nervous system neoplasm	0.000108	0.000187	CcSEcCtD
Zolmitriptan—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000108	0.000187	CcSEcCtD
Zolmitriptan—Headache—Epirubicin—peripheral nervous system neoplasm	0.000107	0.000186	CcSEcCtD
Zolmitriptan—HTR1A—SIDS Susceptibility Pathways—PHOX2B—peripheral nervous system neoplasm	0.000107	0.0268	CbGpPWpGaD
Zolmitriptan—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000105	0.000181	CcSEcCtD
Zolmitriptan—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000102	0.000176	CcSEcCtD
Zolmitriptan—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000101	0.000174	CcSEcCtD
Zolmitriptan—Rash—Doxorubicin—peripheral nervous system neoplasm	0.0001	0.000173	CcSEcCtD
Zolmitriptan—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	9.99e-05	0.000173	CcSEcCtD
Zolmitriptan—Headache—Doxorubicin—peripheral nervous system neoplasm	9.94e-05	0.000172	CcSEcCtD
Zolmitriptan—Nausea—Doxorubicin—peripheral nervous system neoplasm	9.42e-05	0.000163	CcSEcCtD
Zolmitriptan—HTR1F—Class A/1 (Rhodopsin-like receptors)—NTS—peripheral nervous system neoplasm	7.02e-05	0.0176	CbGpPWpGaD
Zolmitriptan—HTR1F—GPCR ligand binding—NTS—peripheral nervous system neoplasm	5.34e-05	0.0134	CbGpPWpGaD
Zolmitriptan—HTR1F—GPCR ligand binding—CD55—peripheral nervous system neoplasm	5.12e-05	0.0129	CbGpPWpGaD
Zolmitriptan—CYP1A2—Aryl Hydrocarbon Receptor—NF1—peripheral nervous system neoplasm	4.89e-05	0.0123	CbGpPWpGaD
Zolmitriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—NTS—peripheral nervous system neoplasm	4.49e-05	0.0113	CbGpPWpGaD
Zolmitriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—NTS—peripheral nervous system neoplasm	4.39e-05	0.011	CbGpPWpGaD
Zolmitriptan—HTR1F—G alpha (i) signalling events—KNG1—peripheral nervous system neoplasm	3.97e-05	0.00997	CbGpPWpGaD
Zolmitriptan—MAOA—SIDS Susceptibility Pathways—NTRK2—peripheral nervous system neoplasm	3.61e-05	0.00908	CbGpPWpGaD
Zolmitriptan—HTR1F—G alpha (i) signalling events—GNAS—peripheral nervous system neoplasm	3.47e-05	0.00872	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCR ligand binding—NTS—peripheral nervous system neoplasm	3.42e-05	0.00859	CbGpPWpGaD
Zolmitriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—NTS—peripheral nervous system neoplasm	3.35e-05	0.00841	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR ligand binding—NTS—peripheral nervous system neoplasm	3.35e-05	0.00841	CbGpPWpGaD
Zolmitriptan—MAOA—SIDS Susceptibility Pathways—TH—peripheral nervous system neoplasm	3.31e-05	0.00832	CbGpPWpGaD
Zolmitriptan—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—peripheral nervous system neoplasm	3.31e-05	0.00831	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCR ligand binding—CD55—peripheral nervous system neoplasm	3.28e-05	0.00824	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR ligand binding—CD55—peripheral nervous system neoplasm	3.21e-05	0.00806	CbGpPWpGaD
Zolmitriptan—HTR1F—Class A/1 (Rhodopsin-like receptors)—KNG1—peripheral nervous system neoplasm	3.15e-05	0.00793	CbGpPWpGaD
Zolmitriptan—HTR1A—SIDS Susceptibility Pathways—NTRK2—peripheral nervous system neoplasm	3.07e-05	0.00772	CbGpPWpGaD
Zolmitriptan—HTR1F—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	3.02e-05	0.00759	CbGpPWpGaD
Zolmitriptan—MAOA—Transmission across Chemical Synapses—BCHE—peripheral nervous system neoplasm	2.88e-05	0.00725	CbGpPWpGaD
Zolmitriptan—HTR1A—SIDS Susceptibility Pathways—TH—peripheral nervous system neoplasm	2.81e-05	0.00707	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling by GPCR—NTS—peripheral nervous system neoplasm	2.74e-05	0.00689	CbGpPWpGaD
Zolmitriptan—MAOA—SIDS Susceptibility Pathways—BDNF—peripheral nervous system neoplasm	2.7e-05	0.00677	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling by GPCR—CD55—peripheral nervous system neoplasm	2.63e-05	0.00661	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR ligand binding—NTS—peripheral nervous system neoplasm	2.55e-05	0.00641	CbGpPWpGaD
Zolmitriptan—HTR1D—G alpha (i) signalling events—KNG1—peripheral nervous system neoplasm	2.54e-05	0.00638	CbGpPWpGaD
Zolmitriptan—HTR1B—G alpha (i) signalling events—KNG1—peripheral nervous system neoplasm	2.48e-05	0.00624	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR ligand binding—CD55—peripheral nervous system neoplasm	2.44e-05	0.00614	CbGpPWpGaD
Zolmitriptan—HTR1F—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	2.4e-05	0.00604	CbGpPWpGaD
Zolmitriptan—HTR1A—SIDS Susceptibility Pathways—BDNF—peripheral nervous system neoplasm	2.29e-05	0.00576	CbGpPWpGaD
Zolmitriptan—HTR1F—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	2.29e-05	0.00575	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—PPIP5K2—peripheral nervous system neoplasm	2.23e-05	0.0056	CbGpPWpGaD
Zolmitriptan—HTR1D—G alpha (i) signalling events—GNAS—peripheral nervous system neoplasm	2.22e-05	0.00557	CbGpPWpGaD
Zolmitriptan—MAOA—Neuronal System—BCHE—peripheral nervous system neoplasm	2.21e-05	0.00556	CbGpPWpGaD
Zolmitriptan—HTR1B—G alpha (i) signalling events—GNAS—peripheral nervous system neoplasm	2.17e-05	0.00546	CbGpPWpGaD
Zolmitriptan—HTR1F—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	2.1e-05	0.00528	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling by GPCR—VIP—peripheral nervous system neoplasm	2.08e-05	0.00522	CbGpPWpGaD
Zolmitriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—KNG1—peripheral nervous system neoplasm	2.02e-05	0.00507	CbGpPWpGaD
Zolmitriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—KNG1—peripheral nervous system neoplasm	1.97e-05	0.00496	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	1.93e-05	0.00485	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	1.92e-05	0.00482	CbGpPWpGaD
Zolmitriptan—HTR1A—G alpha (i) signalling events—KNG1—peripheral nervous system neoplasm	1.89e-05	0.00476	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	1.89e-05	0.00475	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—NTS—peripheral nervous system neoplasm	1.75e-05	0.00441	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—NTS—peripheral nervous system neoplasm	1.72e-05	0.00432	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—CD55—peripheral nervous system neoplasm	1.68e-05	0.00423	CbGpPWpGaD
Zolmitriptan—HTR1A—G alpha (i) signalling events—GNAS—peripheral nervous system neoplasm	1.65e-05	0.00416	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—CD55—peripheral nervous system neoplasm	1.65e-05	0.00414	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—NTS—peripheral nervous system neoplasm	1.62e-05	0.00407	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—CD55—peripheral nervous system neoplasm	1.55e-05	0.0039	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	1.54e-05	0.00386	CbGpPWpGaD
Zolmitriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—KNG1—peripheral nervous system neoplasm	1.5e-05	0.00378	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.5e-05	0.00378	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	1.5e-05	0.00378	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	1.46e-05	0.00368	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	1.44e-05	0.00362	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	1.43e-05	0.0036	CbGpPWpGaD
Zolmitriptan—HTR1F—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	1.36e-05	0.00341	CbGpPWpGaD
Zolmitriptan—MAOA—SIDS Susceptibility Pathways—CASP3—peripheral nervous system neoplasm	1.35e-05	0.00338	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	1.34e-05	0.00338	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—VIP—peripheral nervous system neoplasm	1.33e-05	0.00334	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	1.31e-05	0.0033	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—NTS—peripheral nervous system neoplasm	1.31e-05	0.00329	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—VIP—peripheral nervous system neoplasm	1.3e-05	0.00327	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—CD55—peripheral nervous system neoplasm	1.25e-05	0.00315	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	1.25e-05	0.00313	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	1.23e-05	0.0031	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—VIP—peripheral nervous system neoplasm	1.23e-05	0.00309	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	1.23e-05	0.00308	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	1.2e-05	0.00302	CbGpPWpGaD
Zolmitriptan—HTR1F—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	1.19e-05	0.00298	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	1.15e-05	0.00288	CbGpPWpGaD
Zolmitriptan—HTR1A—SIDS Susceptibility Pathways—CASP3—peripheral nervous system neoplasm	1.14e-05	0.00288	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	1.13e-05	0.00285	CbGpPWpGaD
Zolmitriptan—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—peripheral nervous system neoplasm	1.11e-05	0.00278	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	1.09e-05	0.00274	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—GNS—peripheral nervous system neoplasm	1.09e-05	0.00273	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	1.08e-05	0.00271	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—NME1—peripheral nervous system neoplasm	1.04e-05	0.00262	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—NTS—peripheral nervous system neoplasm	1.04e-05	0.0026	CbGpPWpGaD
Zolmitriptan—CYP1A2—Aryl Hydrocarbon Receptor—MYC—peripheral nervous system neoplasm	1.03e-05	0.00259	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—NTS—peripheral nervous system neoplasm	1.01e-05	0.00255	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—COX2—peripheral nervous system neoplasm	1e-05	0.00252	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	1e-05	0.00252	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—CD55—peripheral nervous system neoplasm	9.93e-06	0.0025	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—VIP—peripheral nervous system neoplasm	9.92e-06	0.00249	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—CD55—peripheral nervous system neoplasm	9.73e-06	0.00244	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	9.15e-06	0.0023	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	8.68e-06	0.00218	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	8.51e-06	0.00214	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	8.5e-06	0.00214	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—PPIP5K2—peripheral nervous system neoplasm	8.21e-06	0.00206	CbGpPWpGaD
Zolmitriptan—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—peripheral nervous system neoplasm	8.09e-06	0.00203	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	7.88e-06	0.00198	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—VIP—peripheral nervous system neoplasm	7.85e-06	0.00197	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—NTS—peripheral nervous system neoplasm	7.73e-06	0.00194	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	7.72e-06	0.00194	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—VIP—peripheral nervous system neoplasm	7.69e-06	0.00193	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	7.59e-06	0.00191	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	7.49e-06	0.00188	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	7.43e-06	0.00187	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—CD55—peripheral nervous system neoplasm	7.41e-06	0.00186	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—KNG1—peripheral nervous system neoplasm	7.28e-06	0.00183	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	7.25e-06	0.00182	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	7.1e-06	0.00178	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	6.94e-06	0.00174	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	6.89e-06	0.00173	CbGpPWpGaD
Zolmitriptan—MAOA—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	6.77e-06	0.0017	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	6.75e-06	0.0017	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—ENO2—peripheral nervous system neoplasm	6.59e-06	0.00166	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	6.47e-06	0.00163	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—GNAS—peripheral nervous system neoplasm	6.37e-06	0.0016	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	5.88e-06	0.00148	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—VIP—peripheral nervous system neoplasm	5.86e-06	0.00147	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	5.66e-06	0.00142	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—BCHE—peripheral nervous system neoplasm	5.57e-06	0.0014	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—HSD17B12—peripheral nervous system neoplasm	5.55e-06	0.00139	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	5.44e-06	0.00137	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	5.41e-06	0.00136	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	5.33e-06	0.00134	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—SLC2A1—peripheral nervous system neoplasm	5.31e-06	0.00133	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—TH—peripheral nervous system neoplasm	5.23e-06	0.00132	CbGpPWpGaD
Zolmitriptan—MAOA—Neuronal System—HRAS—peripheral nervous system neoplasm	5.19e-06	0.0013	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	5.14e-06	0.00129	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	4.79e-06	0.0012	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	4.69e-06	0.00118	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—KNG1—peripheral nervous system neoplasm	4.66e-06	0.00117	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	4.61e-06	0.00116	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—KNG1—peripheral nervous system neoplasm	4.56e-06	0.00115	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	4.5e-06	0.00113	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	4.44e-06	0.00112	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	4.42e-06	0.00111	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	4.34e-06	0.00109	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—GNAS—peripheral nervous system neoplasm	4.27e-06	0.00107	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—ABCB1—peripheral nervous system neoplasm	4.19e-06	0.00105	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—GNAS—peripheral nervous system neoplasm	4.07e-06	0.00102	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	4.06e-06	0.00102	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—GNS—peripheral nervous system neoplasm	4.01e-06	0.00101	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—GNAS—peripheral nervous system neoplasm	3.99e-06	0.001	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—NME1—peripheral nervous system neoplasm	3.84e-06	0.000966	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—COX2—peripheral nervous system neoplasm	3.7e-06	0.00093	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	3.57e-06	0.000898	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	3.5e-06	0.000879	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—KNG1—peripheral nervous system neoplasm	3.47e-06	0.000873	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	3.31e-06	0.000832	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	3.29e-06	0.000828	CbGpPWpGaD
Zolmitriptan—HTR1F—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	3.2e-06	0.000805	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—CASP3—peripheral nervous system neoplasm	3.17e-06	0.000798	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—GNAS—peripheral nervous system neoplasm	3.04e-06	0.000763	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	2.91e-06	0.000731	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	2.88e-06	0.000724	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	2.83e-06	0.000711	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	2.82e-06	0.000709	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	2.77e-06	0.000696	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—NRAS—peripheral nervous system neoplasm	2.66e-06	0.000669	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—MYC—peripheral nervous system neoplasm	2.48e-06	0.000623	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—ENO2—peripheral nervous system neoplasm	2.43e-06	0.000611	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	2.24e-06	0.000562	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	2.19e-06	0.00055	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	2.15e-06	0.00054	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	2.11e-06	0.00053	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	2.11e-06	0.00053	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	2.06e-06	0.000518	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—BCHE—peripheral nervous system neoplasm	2.05e-06	0.000516	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	2.05e-06	0.000515	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—TP53—peripheral nervous system neoplasm	2.03e-06	0.000511	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—CASP3—peripheral nervous system neoplasm	2.03e-06	0.00051	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	2.01e-06	0.000504	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.99e-06	0.000499	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.96e-06	0.000492	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.95e-06	0.000489	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—TH—peripheral nervous system neoplasm	1.93e-06	0.000485	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.86e-06	0.000468	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.82e-06	0.000458	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.72e-06	0.000432	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.7e-06	0.000428	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.67e-06	0.000419	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.67e-06	0.000419	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.58e-06	0.000398	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—GNAS—peripheral nervous system neoplasm	1.58e-06	0.000396	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.57e-06	0.000395	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.55e-06	0.00039	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—ABCB1—peripheral nervous system neoplasm	1.55e-06	0.000389	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.53e-06	0.000384	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.51e-06	0.00038	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.39e-06	0.000349	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.3e-06	0.000327	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.27e-06	0.00032	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.27e-06	0.000319	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.24e-06	0.000313	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.22e-06	0.000306	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.18e-06	0.000297	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—AKT1—peripheral nervous system neoplasm	1.15e-06	0.00029	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.1e-06	0.000276	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.08e-06	0.00027	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—TP53—peripheral nervous system neoplasm	9.71e-07	0.000244	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	9.28e-07	0.000233	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	8.2e-07	0.000206	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—AKT1—peripheral nervous system neoplasm	4.25e-07	0.000107	CbGpPWpGaD
